450 related articles for article (PubMed ID: 9065649)
1. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
[TBL] [Abstract][Full Text] [Related]
2. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.
Cortesina G; Martone T; Galeazzi E; Olivero M; De Stefani A; Bussi M; Valente G; Comoglio PM; Di Renzo MF
Int J Cancer; 2000 May; 89(3):286-92. PubMed ID: 10861506
[TBL] [Abstract][Full Text] [Related]
3. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression.
Beviglia L; Matsumoto K; Lin CS; Ziober BL; Kramer RH
Int J Cancer; 1997 Jun; 74(3):301-9. PubMed ID: 9221809
[TBL] [Abstract][Full Text] [Related]
4. Stimulatory effects of hepatocyte growth factor on normal and neoplastic human bronchial epithelial cells.
Singh-Kaw P; Zarnegar R; Siegfried JM
Am J Physiol; 1995 Jun; 268(6 Pt 1):L1012-20. PubMed ID: 7611423
[TBL] [Abstract][Full Text] [Related]
5. c-met proto-oncogene expression in benign and malignant human prostate tissues.
Pisters LL; Troncoso P; Zhau HE; Li W; von Eschenbach AC; Chung LW
J Urol; 1995 Jul; 154(1):293-8. PubMed ID: 7539865
[TBL] [Abstract][Full Text] [Related]
6. Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression.
Natali PG; Nicotra MR; Di Renzo MF; Prat M; Bigotti A; Cavaliere R; Comoglio PM
Br J Cancer; 1993 Oct; 68(4):746-50. PubMed ID: 8104462
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
8. c-met overexpression in supraglottic laryngeal squamous cell carcinoma and its relation to lymph node metastases.
Yücel OT; Sungur A; Kaya S
Otolaryngol Head Neck Surg; 2004 Jun; 130(6):698-703. PubMed ID: 15195055
[TBL] [Abstract][Full Text] [Related]
9. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
Kim CH; Kim J; Kahng H; Choi EC
Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the met/HGF receptor in renal cell carcinomas.
Natali PG; Prat M; Nicotra MR; Bigotti A; Olivero M; Comoglio PM; Di Renzo MF
Int J Cancer; 1996 Jun; 69(3):212-7. PubMed ID: 8682590
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas.
Di Renzo MF; Olivero M; Ferro S; Prat M; Bongarzone I; Pilotti S; Belfiore A; Costantino A; Vigneri R; Pierotti MA
Oncogene; 1992 Dec; 7(12):2549-53. PubMed ID: 1334253
[TBL] [Abstract][Full Text] [Related]
12. Expression of scatter factor and c-met receptor in benign and malignant breast tissue.
Jin L; Fuchs A; Schnitt SJ; Yao Y; Joseph A; Lamszus K; Park M; Goldberg ID; Rosen EM
Cancer; 1997 Feb; 79(4):749-60. PubMed ID: 9024713
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.
Humphrey PA; Zhu X; Zarnegar R; Swanson PE; Ratliff TL; Vollmer RT; Day ML
Am J Pathol; 1995 Aug; 147(2):386-96. PubMed ID: 7639332
[TBL] [Abstract][Full Text] [Related]
14. HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer.
Knowles LM; Stabile LP; Egloff AM; Rothstein ME; Thomas SM; Gubish CT; Lerner EC; Seethala RR; Suzuki S; Quesnelle KM; Morgan S; Ferris RL; Grandis JR; Siegfried JM
Clin Cancer Res; 2009 Jun; 15(11):3740-50. PubMed ID: 19470725
[TBL] [Abstract][Full Text] [Related]
15. Characterization of ten newly-derived human head and neck squamous carcinoma cell lines with special reference to c-erbB proto-oncogene expression.
O-Charoenrat P; Rhys-Evans P; Eccles S
Anticancer Res; 2001; 21(3B):1953-63. PubMed ID: 11497283
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas.
Di Renzo MF; Olivero M; Martone T; Maffe A; Maggiora P; Stefani AD; Valente G; Giordano S; Cortesina G; Comoglio PM
Oncogene; 2000 Mar; 19(12):1547-55. PubMed ID: 10734314
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer.
Nagy J; Curry GW; Hillan KJ; McKay IC; Mallon E; Purushotham AD; George WD
Surg Oncol; 1996 Feb; 5(1):15-21. PubMed ID: 8837300
[TBL] [Abstract][Full Text] [Related]
19. MET receptor is overexpressed but not mutated in oral squamous cell carcinomas.
Morello S; Olivero M; Aimetti M; Bernardi M; Berrone S; Di Renzo MF; Giordano S
J Cell Physiol; 2001 Dec; 189(3):285-90. PubMed ID: 11748586
[TBL] [Abstract][Full Text] [Related]
20. Roles of the HGF/Met signaling in head and neck squamous cell carcinoma: Focus on tumor immunity (Review).
Liu D; Zhong M; Zhan D; Zhang Y; Liu S
Oncol Rep; 2020 Dec; 44(6):2337-2344. PubMed ID: 33125120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
